Senzime

📍 Uppsala, Sweden🗓 Founded 1999👥 50 employees💰 Last funded Oct 2020
Medical Equipment Manufacturing🌐 senzime.com
Website LinkedIn
Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications. The company markets an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures. Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world’s leading markets. The company’s shares are listed on Nasdaq Stockholm Main Market (SEZI).
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Senzime?
Senzime has 1 investors on record on gritt.io.
When did Senzime last raise funding?
The most recent investment in Senzime recorded on gritt.io was in October 2020.
When was Senzime founded?
Senzime was founded in 1999.
What industry is Senzime in?
Senzime operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Senzime based?
Senzime is headquartered in Uppsala, Sweden.